Palisade Bio Inc (PALI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,261 | 11,589 | 14,026 | 7,515 | 2,310 |
| Other current assets | 322 | 0 | 0 | 0 | 0 |
| TOTAL | $9,830 | $11,891 | $14,298 | $7,647 | $2,453 |
| Non-Current Assets | |||||
| PPE Net | 200 | 163 | 187 | 202 | 197 |
| Intangibles | 500 | 440 | 370 | 320 | 302 |
| Other Non-Current Assets | 61 | 49 | 49 | 49 | 56 |
| TOTAL | $761 | $653 | $607 | $571 | $554 |
| Total Assets | $10,591 | $12,544 | $14,905 | $8,218 | $3,007 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,033 | 1,214 | 1,145 | 923 | 792 |
| Accrued Expenses | 453 | 510 | 588 | 775 | 769 |
| Other current liabilities | 1,251 | 2,204 | 2,189 | 1,498 | N/A |
| TOTAL | $2,737 | $3,928 | $3,922 | $3,195 | $1,561 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 6,462 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $6,462 |
| Total Liabilities | $2,737 | $3,928 | $3,922 | $3,195 | $8,023 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 48,366 | 46,473 | 46,008 | 42,251 | 42,821 |
| Common Shares | 469 | 462 | 460 | 423 | 357 |
| Retained earnings | -85,954 | -83,215 | -79,285 | -74,334 | -67,567 |
| TOTAL | $7,854 | $8,615 | $10,983 | $5,023 | $-5,016 |
| Total Liabilities And Equity | $10,591 | $12,544 | $14,905 | $8,218 | $3,007 |